IndexIQ Advisors’s Amgen AMGN Stock Holding History

IndexIQ Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.44M	Buy	10,095 +225	+2%	+$51.7K	0.09%	213
2021 Q4	$2.22M	Sell	9,870 -91	-0.9%	-$19.2K	0.07%	218
2021 Q3	$2.12M	Buy	9,961 +465	+5%	+$107K	0.07%	233
2021 Q2	$2.31M	Buy	9,496 +177	+2%	+$43.5K	0.08%	212
2021 Q1	$2.32M	Sell	9,319 -8,219	-47%	-$1.96M	0.08%	210
2020 Q4	$4.03M	Buy	17,538 +3,815	+28%	+$880K	0.15%	98
2020 Q3	$3.49M	Buy	13,723 +2,591	+23%	+$642K	0.14%	92
2020 Q2	$2.63M	Buy	+11,132	New	+$2.54M	0.12%	111
2020 Q1	–	Sell	-207	Closed	-$50K	–	1026
2019 Q4	$50K	Buy	+207	New	+$45.6K	﹤0.01%	547

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

IndexIQ Advisors's AMGN Position: Q1 2022 in Review

IndexIQ Advisors increased its Amgen (AMGN) stake by 2.3% in Q1 2022, buying an estimated $51.7K and bringing the position to 10,095 shares worth $2.44M. The position accounts for 0.09% of the portfolio, ranked #213.

IndexIQ Advisors first reported a position in AMGN in Q4 2019 and has held it in 9 quarters since. The position peaked at $4.03M in Q4 2020. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

IndexIQ Advisors held 10,095 shares of Amgen worth $2.44M as of Q1 2022.
IndexIQ Advisors bought 225 Amgen shares in Q1 2022, an estimated $51.7K.
Amgen made up 0.09% of IndexIQ Advisors's portfolio in Q1 2022, its #213 holding.
IndexIQ Advisors first reported a position in Amgen in Q4 2019 and has held it in 9 quarters since.
IndexIQ Advisors's Amgen position peaked at $4.03M in Q4 2020.
2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.